SABINA: An Overview of Short-Acting β(2)-Agonist Use in Asthma in European Countries

INTRODUCTION: Globally, individuals with asthma tend to overrely on short-acting β(2)-agonists (SABAs) and underuse inhaled corticosteroids, thereby undertreating the underlying inflammation. Such relief-seeking behavior has been reinforced by long-standing treatment guidelines, which until recently...

Descripción completa

Detalles Bibliográficos
Autores principales: Janson, Christer, Menzies-Gow, Andrew, Nan, Cassandra, Nuevo, Javier, Papi, Alberto, Quint, Jennifer K., Quirce, Santiago, Vogelmeier, Claus F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089727/
https://www.ncbi.nlm.nih.gov/pubmed/31981105
http://dx.doi.org/10.1007/s12325-020-01233-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089727/
https://www.ncbi.nlm.nih.gov/pubmed/31981105
http://dx.doi.org/10.1007/s12325-020-01233-0

Ejemplares similares